ID
34935
Description
Study ID: 101888 Clinical Study ID: FFR101888 Study Title: A randomised, placebo-controlled, four way crossover study to evaluate the effect of double-blind 4000 mcg of orally inhaled GW685698X and of 6.25 mg cellobiose octa-acetate on electrocardiographic parameters, with single-blind 400 mg of oral moxifloxacin as a positive control, in 40 healthy male and female subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: Veramyst,Avamys,Allermist Study Indication: Rhinitis, Allergic, Perennial The study consists of a screening, 4 treatment periods (TP) and a follow-up visit. For each TP there is a Day-1 (D-1) and a Day1 (D1). This document contains the 12-lead ECG form. It has to be filled in for TP1-4 Day1.
Keywords
Versions (1)
- 2/4/19 2/4/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
February 4, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effect of inhaled Fluticasone furoate and cellobiose octa-acetate on electrocardiographic parameters in healthy subjects, Study-ID: 101888
12-lead ECG for TP1-4 Day1
- StudyEvent: ODM
Description
12-LEAD ECG
Alias
- UMLS CUI-1
- C0430456
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C0808070
Description
Three measurements, at least 2 minutes apart, will be taken at each specified time – the subject having rested in the supine position for at least 5 minutes before the first measurement. The mean of the three scheduled values recorded immediately pre-dose will be defined as baseline.
Data type
integer
Alias
- UMLS CUI [1]
- C0439564
Description
00:00-23:59
Data type
time
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C1301880
Description
Ventricular Rate
Data type
integer
Measurement units
- beats/min
Alias
- UMLS CUI [1]
- C2189285
Description
PR Interval
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1]
- C0429087
Description
QRS Duration
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1]
- C0429025
Description
Uncorrected QT Interval
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1]
- C1287082
Description
QTc Interval
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1]
- C0855331
Description
QTc (F)
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1]
- C1882513
Description
If a subject’s QTcF interval extends beyond 500msec or is increased more than 60msec compared to baseline (confirmed on three or more ECG tracings separated by at least 2 minutes), the ECG tracing should be examined by an appropriately trained physician and manual measurements undertaken. If the reading is confirmed, the subject should be closely monitored and followed in the clinical unit until the QT and QTc(F) interval return to within 30msec of their baseline.
Data type
integer
Measurement units
- msec
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
- UMLS CUI [1,3]
- C0175674
Description
enter code for result from the following list. If you tick Abnormal-clinically significant: Complete the Serious Adverse Event (SAE) page(s) if clinically significant abnormalities meet the protocol definition for a SAE. Complete the additional ECG Abnormalities page if clinically significant abnormalities are present.
Data type
integer
Alias
- UMLS CUI [1]
- C0438154
Similar models
12-lead ECG for TP1-4 Day1
- StudyEvent: ODM
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
C0175674 (UMLS CUI [1,3])
No comments